Search clinical trials for: RF-CWC

Total 1782 results

Celgene Corporation
Prologue Research International

Completed

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkins Lymphoma

United States
M.D. Anderson Cancer Center
Celgene Corporation

Completed

A Phase II Study of CC-5013 in Myelofibrosis

Myelofibrosis

United States
Yonsei University

Recruiting

Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study

Hypertension

Korea, Republic of
Takeda

Completed

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

Healthy Volunteers

United States
Centre Hospitalier Universitaire de Besancon

Completed

Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors (EPICentro)

Neuroendocrine Tumors

France
Celgene

Terminated

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma (KarMMa-7)

Multiple Myeloma

United States, Spain
Celgene

Terminated

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease

Systemic Sclerosis | Scleroderma, Systemic | Systemic Scleroderma | Interstitial Lung Disease | Sclerosis, Systemic

United States, Spain, France, Australia, Italy, Switzerland, Germany, Poland, United Kingdom, Russian Federation
The Cleveland Clinic

Completed

Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study

Hereditary Hemorrhagic Telangiectasia | Idiopathic Vascular Ectasia

United States
Celgene

Completed

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Leukemia, B-Cell, Chronic

Canada, United States, Germany, Italy, Spain, Sweden, United Kingdom
Sohag University

Completed

Nutritional Deficiency After Bariatric Surgeries

Nutritional Deficiency

Egypt
McGill University

Completed

Inhaled Fentanyl Citrate & Dyspnea

Dyspnea

Canada
Penn State University
Purdue University

Active, not recruiting

Assessing the Impact of Contraceptives on Bone Health Using 41Ca

Other Disorders of Bone Development and Growth

United States
Population Council
University of Zimbabwe

Completed

A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention (952)

HIV Infections | Contraception

Zimbabwe
Cairo University

Completed

The Effect of Oral Contraceptives on Women Balance

Joint Stabilioty

Egypt
UNC Lineberger Comprehensive Cancer Center

Terminated

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

Prostate Cancer

United States
Celgene

Completed

Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) (PASS MDS del5q)

Myelodysplastic Syndrome

Spain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
Weill Medical College of Cornell University

Terminated

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue

Leukemia | CLL

United States
Celgene

Completed

Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

Myelodysplastic Syndromes

United States, Germany
Celgene

Completed

A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects

Healthy

United States
Celgene
ICON Clinical Research

Completed

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

Melanoma | Neoplasm Metastasis

Australia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
Chang Gung Memorial Hospital

Completed

Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer

Latent Cancer Prostate

Taiwan
Jason Robert Gotlib
Celgene Corporation

Terminated

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Leukemia | Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Kidney Cancer

United States
Washington University School of Medicine

Completed

CC-4047 (Pomalidomide) for Graft vs. Host Disease

Graft vs Host Disease

United States
The Christie NHS Foundation Trust
Celgene Corporation; Leukemia Research Fund

Terminated

RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial (RESPeCT)

Chronic Lymphocytic Leukaemia

United Kingdom
Celgene Corporation

Completed

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Not yet recruiting

Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Autoimmune Hemolytic Anemia | Chronic Immune Thrombocytopenia

United States, Denmark, Germany, United Kingdom
Ramathibodi Hospital

Completed

Perioperative Outcome of Corticosteroids in Transforaminal Endoscopic Lumbar Discectomy

Lumbar Disc Herniation
Jonsson Comprehensive Cancer Center
Novartis Pharmaceuticals

Recruiting

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Prostate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
Melissa J. Schoelwer

Completed

Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery (InsuLearn-SMA)

Type 1 Diabetes

United States
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
OSI Pharmaceuticals
Canadian Cancer Trials Group

Completed

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Pancreatic Cancer

United States, Canada, Australia, Israel, Singapore, United Kingdom, Germany, Belgium, Romania, Poland, Argentina, Brazil, Chile, Greece, Italy, Mexico, New Zealand
Cancer Institute and Hospital, Chinese Academy...

Unknown

IORT Versus CCRT for Pancreatic Cancer (IVCPC)

Pancreatic Cancer Stage IV

China
National Cancer Institute (NCI)

Completed

Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

Multiple Myeloma

United States, Puerto Rico
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Medical University of South Carolina
Celgene Corporation

Completed

Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Large B-Cell Diffuse Lymphoma

United States
Gesellschaft fur Medizinische Innovation - Hamatologie...
ClinAssess GmbH

Completed

Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q (MDS-LE-MON-5)

Myelodysplastic Syndromes

Germany
Celgene

No longer available

Expanded Access for CC-4047

Multiple Myeloma

United States
Celgene Corporation

Completed

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

Radiculopathy

United States
Franck Boccara

Completed

French CAC-HIV Cohort Study (CAC-HIV)

HIV Infections | Coronary Artery Calcification
University of Gaziantep

Completed

The Effects of Sevoflurane and Desflurane Used in Low-Flow Anesthesia on Thiol Disulfide Homeostasis

Low Flow Anesthesia

Turkey
Jules Bordet Institute

Withdrawn

Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management (ProsPERo)

Prostate Cancers
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...

Completed

Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple Myeloma

United States
Groupe Hospitalier Diaconesses Croix Saint-Simon
GERCOR - Multidisciplinary Oncology Cooperative Group

Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (CHIMOVIP)

Ovarian Cancer, Epithelial

France
Universidad Autonoma de Nuevo Leon

Completed

Metabolic Syndrome and Functional Food

Metabolic Syndrome

Mexico
Celgene

Completed

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

Multiple Myeloma

Belgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
National Cancer Institute (NCI)

Completed

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditions

United States
Washington University School of Medicine
Celgene Corporation

Completed

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Hodgkin Disease

United States
Boston VA Research Institute, Inc.
Dana-Farber Cancer Institute

Completed

Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias

Plasma Cell Disorder

United States

Search clinical trials for: RF-CWC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations